Pierre Blanchard

Pierre Blanchard: Early Toxicity Results from GETUG Adjuvant Radiotherapy Trial after Cystectomy for Bladder Cancer

Pierre Blanchard, Radiation Oncology Clinical Section Chief at Gustave Roussy Cancer Institute, posted on X:

“Paul Sargos presenting very reassuring early toxicity results from GETUG adjuvant radiotherapy trial after cystectomy for bladder cancer.”

Pierre Blanchard: Early Toxicity Results from GETUG Adjuvant Radiotherapy Trial after Cystectomy for Bladder Cancer

ESTRO 2025 Live Updates on OncoDaily.